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ABSTRACT
The Open Regulatory Annotation database (ORe-
gAnno) is a resource for curated regulatory anno-
tation. It contains information about regulatory re-
gions, transcription factor binding sites, RNA bind-
ing sites, regulatory variants, haplotypes, and other
regulatory elements. ORegAnno differentiates it-
self from other regulatory resources by facilitating
crowd-sourced interpretation and annotation of regu-
latory observations from the literature and highly cu-
rated resources. It contains a comprehensive annota-
tion scheme that aims to describe both the elements
and outcomes of regulatory events. Moreover, ORe-
gAnno assembles these disparate data sources and
annotations into a single, high quality catalogue of
curated regulatory information. The current release
is an update of the database previously featured in
the NAR Database Issue, and now contains 1 948 307
records, across 18 species, with a combined cover-
age of 334 215 080 bp. Complete records, annotation,
and other associated data are available for browsing
and download at http://www.oreganno.org/.
INTRODUCTION
The Open Regulatory Annotation database (ORegAnno)
was first released about a decade ago (1), with the inten-
tion to collect and synthesize a catalogue of regulatory ele-
ments. It remains unique in the field because of its focus on
collecting high quality, curated regulatory records from the
literature. Moreover, ORegAnno relies on a thriving com-
munity of scientists who are interested in contributing to the
resource, as well as utilizing its data. Since the last release of
ORegAnno in early 2008 (2), the amount and types of pub-
lished regulatory data have grown exponentially. This re-
lates in part to high-throughput studies from the ENCODE
consortium and others, who have performed an enormous
number of ChIP-seq, DNase-seq, FAIRE-seq and other ex-
periments aiming to identify biochemically available and
transcriptionally active regions of genomes (3). While these
efforts are excellent resources for identifying candidate reg-
ulatory regions, ENCODE efforts have suggested that as
much as 80% of the genome could be functional (3). This
controversial finding has been the focus of much attention
in the community, with several commentaries pointing out
that these types of high-throughput data are prone to over-
estimates due to experimental and statistical methods that
result in a high number of false positive calls (4–6). More-
over, they do not necessarily provide a comprehensive un-
derstanding of all of the elements involved in gene regu-
lation. For example, knowing the region of DNA that is
bound by a transcription factor does not directly indicate
whether the expression of any genes are altered, nor whether
an alteration results in up- versus down-regulation. Valida-
tion of the genomic regions identified by ENCODE and
others requires a large number of low-throughput experi-
mental data paired with careful manual curation. Addition-
ally, much of the available evidence supporting gene regu-
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lation is dispersed across various experiments, specialized
datasets, and individual publications, making it cumber-
some to obtain regulatory information that has been re-
leased by the community across this broad set of sources.
The current version of ORegAnno seeks to address these
issues by cataloging a large number of new, curated, high
quality regulatory records that are derived from published
literature and other data resources.
RESULTS
Overview
The current version of ORegAnno now has a total of 1 948
307 unique records. These records cover a combined 334
215 080 bp across 18 species (Figure 1A and B). The vast
majority of these records are mapped to human and mouse
genomes, with 1 452 466 records in human (261 660 516
bp in the GRCh38/hg38 genome assembly version) and 415
808 records inmouse (57 253 973 bp in theGRCm38/mm10
genome assembly version).
As ameasure of the success of our community-based par-
ticipation, ORegAnno currently has 1044 registered users.
Aside from the principal authors of this paper, 13 301
records have been contributed by members of the broader
community (The Open Regulatory Annotation Consor-
tium). ORegAnno continues to have a robust verification
system to ensure that contributed records are accurate and
appropriately annotated. A set of trusted consortiummem-
bers have been granted a ‘validator’ status, allowing them
to review and up- or down-vote records. This results in in-
dividual record scores that are visible to all users. More-
over, when a record is negatively scored, it will typically be
assigned a deprecated status. ORegAnno additionally in-
cludes an ontology for summarizing the experimental evi-
dence that supports the regulatory elements and outcome
in each record. Together, these features allow users to filter
records according to various quality criteria.
The ORegAnno database has served as a repository
for publishing regulatory sites derived from experimental
data (7), and it has been incorporated into other resources
including the Babelomics (8), cisRED (9), ConTra (10),
GRASP (11), i-cisTarget (12), LASAGNA-Search 2.0 (13),
the UCSC Genome Browser (14) and more. Similarly, the
annotated information included in ORegAnno has been
used to construct gene regulation networks for the devel-
opment of other tools and the analysis of gene expression
data (15–19). ORegAnno records were used in the REC-set
design for a capture sequence reagent (20), and as part of the
definition for regulatory sites of the human genome (tier 2)
in the GenomeModeling System (21), an analysis informa-
tion management system at the McDonnell Genome Insti-
tute ofWashingtonUniversity that has been used to process
over 4800 human whole genome samples, over 40 000 ex-
omes, and over 1400 transcriptomes. Similarly, ORegAnno
has been adapted into the information systems of other re-
search centers including the Broad Institute and Cancer Re-
search UK, where it has been used in the analysis of several
high impact studies (22–25).
Because ORegAnno focuses on curated regulatory infor-
mation, the total genomic coverage found in ORegAnno is
smaller than that identified by resources such as ENCODE
or the ENSEMBL regulatory tracks (26), which are largely
a summary of ENCODE data (Figure 2). This trade off
is part of an effort to ensure that ORegAnno represents a
high-quality curated set of regulatory elements, with the aim
of maintaining a low number of false positive records.
Updates
Older records, including those that were added through
crowd-sourcing efforts via theweb, have been updated to en-
sure that only accurate and up-to-date gene symbols are be-
ing used. This was accomplished through a combination of
automatically updating symbols using NCBI Gene or EN-
SEMBL identifiers, as well as by manually checking incor-
rect and missing data. In addition, previously missing iden-
tifiers from NCBI Gene or ENSEMBL have been added
where possible, allowing for future automated updates to
ensure the accuracy of these gene lists. These updates have
resulted in 423 automated changes and 13,174 manually cu-
rated changes (13 597 total) affecting 10 386 records.
For all ORegAnno records (existing and new), genomic
coordinates have been updated and expanded using liftOver
(27). This involved converting older genomic coordinates to
newer assembly versions, as well as converting coordinates
from new versions to older assemblies. Thus, each record
may now be associated with multiple genomic coordinates
(from multiple assembly versions). For example, since the
last version of ORegAnno was published in 2008, the hu-
man genome assembly versionGRCh38/hg38 was released.
All existing ORegAnno human records having genomic
coordinates based on assembly versions GRCh36/hg18
or GRCh37/hg19 now have additional updated coordi-
nates using GRCh38/hg38. Similarly, new records that
were entered using GRCh38/hg38 coordinates have re-
ceived additional coordinates based on GRCh37/hg19 and
GRCh36/hg18. This allows users to access the genomic co-
ordinates of regulatory regions for the assembly versions
that best suit their purposes. Finally, new types of transcrip-
tional regulation have been defined in the current release
(Figure 1C and D). These includes microRNA and small
non-codingRNAbinding sites, as well as operons that func-
tion to regulate multiple genes under a single promoter.
New records
ORegAnno has maintained a focus on incorporating
records derived from high quality, manually curated evi-
dence for gene regulation. These typically include experi-
mental evidence demonstrating that binding of a regulatory
element to a specific region of DNA or RNA alters cor-
responding gene expression levels. In total, the current re-
lease of ORegAnno contains 2010 unique records covering
112 582 bp derived directly through literature curation, in-
cluding 661 records that have been added since the previous
ORegAnno release.
Highly validated external databases that had been incor-
porated into earlier ORegAnno releases have been updated.
This includes 1874 new records covering an additional 3
591 656 bp derived from VISTA Enhancers (28) (2196 to-
tal records covering 3 996 796 total bp), 2934 new records












Nucleic Acids Research, 2015 3













4 Nucleic Acids Research, 2015
Figure 2. Comparison of the genomic coverage captured by ORegAnno
and the ENSEMBLRegulatory Track. AVenn diagram demonstrates cov-
erage overlaps for human genome assembly version GRCh38/hg38, with
sets sized to scale. The ENSEMBL Regulatory Track is divided into two
main sets, a track overview set and the transcription factor binding site
(TFBS) set.
Regulatory Map (29) (7320 total records covering 899 449
total bp), as well as 2051 new transcription factor binding
site records covering an additional 29 405 bp derived from
REDfly (30) (2695 total records covering 913 486 total bp).
Previously, ORegAnno had imported records from FlyReg
(31), which has since been merged into REDfly.
New records have been created by importing data from
external databases that were not found in previous ORe-
gAnno releases. This includes 1 093 443 records covering
11 780 604 bp imported from the JASPAR CORE database
(32), which contains a curated, non-redundant set of ex-
perimentally obtained transcription factor binding sites in
eukaryotes. 783 742 records covering 300 003 052 bp were
imported from the PAZAR database (33), which included
only records with curated evidence of transcription factor
binding and regulatory sequence annotation across various
species. 11 451 records covering 4 194 677 bp were derived
fromRegulonDB (34), a database of transcriptional regula-
tion inEscherichia coliK-12, and includesmanually curated
records that have been complemented with high through-
put datasets and comprehensive computational predictions.
We combined conserved miRNA target site predictions
from miRanda-mirSVR (35) with experimentally-validated
miRNA-target interaction data from miRTarBase (36),
leading to the addition of 3,072 new ORegAnno records
covering 44 353 bp. 131 records covering 1216 bp were de-
rived fromNFI-RegulomeDB (37), a database with curated
binding sites for the NFI (Nuclear Factor I) family of tran-
scription factors using data from the published literature.
Finally, 51 transcription factor binding site records cover-
ing 7503 bp were created from the PCNE database of phy-
logenetically conserved noncoding elements (38).
Because of the open and accessible design of the ORe-
gAnno database and website, ORegAnno has been used
for submitting published experimental data. Since the pre-
vious ORegAnno release, four datasets derived from high
throughput studies have been submitted, and were sub-
sequently curated to ensure that only regulatory regions
with a high degree of evidence were retained. These include
RELA (p65) ChIP−PET binding sites in humanmonocytes
(39) (489 records covering 52 886 bp), ESR1 binding sites in
humanMCF-7 breast cancer cells (40) (1234 records cover-
ing 165 538 bp), Esr1 binding sites in mouse liver (41) (5568
records covering 2 378 460 bp), and Foxa2 binding sites in
mouse liver (7) (11 475 records covering 8 236 933 bp). In
all of these cases, DNA sequences were filtered according to
signal strength and proximity to signal peak to reduce false
positive calls. A summary of the number of records and ge-
nomic coverage contributed by each data source is shown in
Figure 1E, F and Supplementary Table S1.
Data access
The ORegAnno database continues to be accessible under
an open-source license (GNU Lesser General Public Li-
cense), in order to encourage development and participa-
tion from the community. Monthly ORegAnno database
summaries are automatically performed and provide fun-
damental regulatory information fromORegAnno in a tab-
delimited text file that is available for free download, with-
out the need to register with the ORegAnno website (http:
//www.oreganno.org/).
The ORegAnno website back end code has been up-
dated to improve security and performance, and to accom-
modate the new data types, dataset sources, and the in-
creased number of records that have been added since the
previous release. New search functionality has been added,
including the ability to browse records by transcription
factor/regulatory element of interest. Source code for the
ORegAnno website is available at https://java.net/projects/
oreganno/.
The regulatory regions and associated annotation for
all supported species have been submitted to the UCSC
Genome Browser (14) as updates to existing ORegAnno
tracks. This updates existing tracks with a more compre-
hensive collection of putatively regulatory elements, and ad-
ditionally provides new tracks on several genome assembly
versions.
Applications
Recently, there has been immense focus on the role of reg-
ulatory regions in cancer. In particular, recurrent somatic
mutations in the TERT promoter have been identified in
various cancer types (42–45), and are associated with in-
creased expression of TERT. Although the importance of
TERT up-regulation in cancer has been well-established
for nearly two decades (46), it is only in recent years that
we’ve identified the regulatory mechanism driving TERT
up-regulation in such cases. While additional efforts have
identified a small number of other recurrent regulatory mu-
tations in cancer (47–49), this number is far smaller than the
recurrent protein-coding mutations that have been identi-
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Figure 3. Capture reagent using ORegAnno sites improves coverage of regulatory regions in human hepatocellular carcinoma. (A) Coverage across the
entire ‘regulome’ is visualized as a heatmap for each of the ten HCC cases. WRS samples have greater sequencing read depth across the targeted region,
compared with WGS samples. (B) An illustrative IGV (51) screenshot is shown of the TERT promoter for one HCC case. A canonical C228T somatic
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cancer survey projects have focused primarily on coding re-
gions by using exome capture reagents to enrich for these
regions, and that the TERT promoter region, as with many
other genes, has a high GC content making both PCR am-
plification and sequencing challenging.
Previous identification of coding regions of the genome
made it possible to perform exome targeted sequencing of
these regions in a large number of cancer cases at a rela-
tively low cost. Similarly, we’ve used ORegAnno and other
sources to design a ‘regulome’ capture reagent for targeted
sequencing. The high quality, relatively small coverage of
literature-curated transcription factor binding sites, regula-
tory polymorphisms, andNFI-RegulomeDB (37) sites iden-
tified in ORegAnno, in conjunction with regulatory regions
defined by FunSeq (50), and 500 bp regions upstream of
each gene transcription start site, were used to define the
‘regulome’ region. As a proof of principle, we then applied
‘regulome’ capture-sequencing to ten normal/tumor pairs
of hepatocellular carcinoma (HCC). Overall coverage of
the regulatory region defined in the capture reagent was
higher in whole regulome sequencing (WRS) samples ver-
sus whole genome sequencing (WGS) samples of the same
tissues, with median average read depths of 29× in WGS
normal, 49× in WGS tumor, 60× in WRS normal and 68×
in WRS tumor (Figure 3A, Supplementary Table S2). This
improved coverage allowed us to reliably identify the canon-
ical somatic TERT promoter mutation C228T in six of the
ten cases, an illustrative example of which is shown in Fig-
ure 3B.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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